by Stefan Leonhardt, Kumovis
We at Kumovis developed a specialized 3d-printing system including clean-room technology. It is capable of processing high performance polymers like PEEK, PEKK, Ultem or PPSU. Furthermore, a special focus is set on degradable polymers.
At the conference we will present our technology and show results regarding achievable clean-room class inside our 3d-printing system. Also first clinical use-cases like using our technology for the lower jaw reconstruction will be presented.
What drives you?
3D-printing will change the future of how we design and produce things. For the first time we have a technology that enables us to produce parts with a design that mimics structures that nature developed over many many years. This gives us the opportunity to create real value for patients.
Why should the delegate attend your presentation?
We are one of the first companies that developed a 3d-printing system that is capable of processing established high-performance polymers like PEEK, and that right at the point of care. Our 3d-printing technology can be set up directly at the point of care, for example in a hospital. It is a system that was designed from the beginning on for the use in medical environment.
What emerging technologies/trends do you see as having the greatest potential in the short and long run?
At the moment there are huge developments with new materials. For example degradable polymers that can be used for 3d printing. These materials can have a great potential for tissue engineering of individualized medications. In the long term run they also can have a huge potential to boost bioprinting.
What are the barriers that might stand in the way?
One major issue always will be regulatory things. Of course we need a regulation to ensure safety and reliability for all patients. On the other hand regulations are often not clear and are more a hurdle than good guideline that helps to bring the technology to patients.
About Stefan Leonhardt
I studied medical engineering at the Technical University of Munich. In 2015 I started my PhD program at the Institute of Medical and Polymer Engineering. There I also met my colleagues and co-founders of our company Kumovis. In 2019 if also finished my MBA program with a focus on digitalization and new business models.
Kumovis develops 3D-printing systems for high perfomance polymers. Our systems are designed from the beginning on to be used in medical environment.